Skip to main content
Premium Trial:

Request an Annual Quote

USPTO Reaffirms Rejection of Helicos Patent

Premium

The United States Patent and Trademark Office has reaffirmed its rejection of the last of four patents owned by Helicos BioSciences that are subject to an inter partes reexamination.

In early January, the USPTO issued a so-called action closing prosecution for the patent, US Patent No. 7,767,400, in which it maintained its initial non-final rejection of all of its claims.

Last year, the office had already issued ACPs for the other three patents under reexamination, US Patents No. 7,037,687, No. 7,169,560, and No. 7,645,596 (IS 10/25/2012).

Pacific Biosciences had requested the reexamination of all four patents last year. The USPTO granted the request last spring, rejecting their claims in a non-final office action.

PacBio's request followed after Helicos sued PacBio, Life Technologies, and Illumina in 2010, claiming that their respective technologies infringe on the patents. That action is still ongoing.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.